Skip to main content
OpenTrials

Clinical trial condition

Thrombocythemia, Essential

Explore clinical trials studying Thrombocythemia, Essential. Study availability and eligibility vary by location and protocol.

184 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Thrombocythemia, Essential trial results

Completed

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

NCT01520220

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington D.C., District of Columbia, United States
View Trial Details
Completed

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

NCT00052520

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +55 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

NCT02125318

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +21 more
Locations
  • East Valley Hematology and Oncology Medical Group Burbank, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Escondido, California, United States
  • California Cancer Associates For Research and Excellence Fresno, California, United States
View Trial Details
Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details
Completed

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

NCT01259817

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • The Palo Alto Clinic Palo Alto, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Emory Hospital Atlanta, Georgia, United States
View all 21 locations
View Trial Details
Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details
Completed

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia

NCT01230775

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Uniklinik Innsbruck Innsbruck, Austria
  • Universitätsklinik für Innere Medizin III, Universitätsklinikum Salzburg Salzburg, Austria
  • Hanusch Krankenhaus Vienna, Austria
  • Sozialmedizinisches Zentrum Ost Vienna, Austria
View all 37 locations
View Trial Details
Completed

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera

NCT01243073

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • MDACC - Orlando Orlando, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University - Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States
View Trial Details

Related conditions